Keywords: mylan, watson, et, al, sue, fda, b-ms

Mylan, Watson, et al sue FDA, B-MS and others over US buspirone patent

Article | 01 December 2000

Print This

The announcement last week by Bristol-Myers Squibb of a new US patent ona metabolite produced in the body after administration ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in